The healthcare sector recorded 78 deals worth $1.9 billion. With deal volumes holding steady, even as overall volumes moderated in the absence of large ticket transactions. According to the report, Grant Thornton Bharat said mergers and acquisitions accounted for 30 deals worth sent $915 million.
The modernisation in the deals landscape was primarily driven by softer M&A volumes, even as private equity activity remained resilient in terms of participation. The over trend indicates a more selective investment environment, which sustains interest in mid-market and growth stage opportunities despite cautious capital deployment.
Meanwhile, outbound expansion and portfolio reorganization by pharmaceutical companies reflect a strategic piworts towards long-term value creation and global competitiveness. Domestic transactions continued to dominate in terms. The deal size remains small, and most transactions are under 50 million.
These transects are very high in number, so they have created their own special account. It is pointing toward the mid-market. Consolidation driven by the regional hospital. Also, with the acquisition and pharma deals.
Here you can see the private equity and venture capital activity comprising 45 deals. Which is worth $456 million. The segment’s highest deal volumes since Q2 2022 and up around 22 per cent rise sequentially. People must take care of their health and keep live longer.
More Stories
Amar Bakery by Raju Carries Forward a 3rd Generation Legacy with Shalimar Garden Launch
Petrol, Diesel prices today, April 15, 2026: Check rates in Delhi, Mumbai, Kolkata, Chennai and more
Capital Goods Stocks Navigate Growth and Geopolitical Risks